A pharmaceutical company is currently appealing a record USD1.6 billion judgment in the US, arguing that a key part of the US False Claims Act (FCA) is unconstitutional. This case, now before the Court of Appeals for the...more
7/30/2025
/ Appeals ,
Constitutional Challenges ,
Enforcement Actions ,
False Claims Act (FCA) ,
Government Agencies ,
Healthcare Fraud ,
Medicare ,
Pharmaceutical Industry ,
SCOTUS ,
United States ex rel Polansky v Executive Health Resources Inc ,
Whistleblower Protection Policies ,
Whistleblowers
One day after her confirmation on February 4, 2025, Attorney General Pam Bondi issued two Memos addressed to the entire U.S. Department of Justice (DOJ), which curtailed enforcement under the Foreign Corrupt Practices Act...more
On June 29th, 2017, the U.S. Commodity Futures Trading Commission (CFTC) entered into the first public non-prosecution agreements in its history with three former Citigroup traders, pledging not to pursue civil...more